ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

CYRN CYREN Ltd

0.2182
0.00 (0.00%)
Pre Market
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
CYREN Ltd NASDAQ:CYRN NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.2182 0.21 0.2146 0 01:00:00

Current Report Filing (8-k)

17/01/2023 9:16pm

Edgar (US Regulatory)


0001084577 false 00-0000000 IL 0001084577 2023-01-12 2023-01-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): January 12, 2023

CYREN LTD.

(Exact Name of Registrant as Specified in its Charter)

Israel   000-26495   Not applicable
(State or Other Jurisdiction
of Incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

10 Ha-Menofim St., 5th Floor
Herzliya, Israel
  4672561
(Address of Principal Executive Offices)   (Zip Code)

 

011972–9–863–6888

(Registrant’s telephone number, including area code)

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class   Trading symbol(s)   Name of exchange on which
registered
Ordinary Shares, par value ILS 3.0 per share   CYRN   Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers

On January 12, 2023, the Board of Directors (the “Board”) of Cyren Ltd. (the “Company”) appointed Jeffrey Dauer as the Company’s Chief Financial Officer and Chief Accounting Officer. Prior to joining the Company, Mr. Dauer, 60 years old, held the Chief Financial Officer and Chief Accounting Officer roles at Comstock Homebuilding Companies and Chief Financial Officer at iControl Data Solutions and Vice President of Finance at ID.me.  Mr. Dauer holds a Bachelor’s degree from Kent State University and is also a Certified Public Accountant (inactive). Mr. Dauer will be paid a rate of $175 per hour. Simulataneous, with the appointment of Mr. Dauer, the Company terminated Brady Hayden as its Principal Accounting Officer. Subject to his execution of a release, Mr. Hayden will be entitled to certain rights and benefits associated with a termination without cause.

 

There is no arrangement or understanding with any person pursuant to which Mr. Dauer was appointed as Chief Financial Officer and Chief Accounting Officer, and there are no family relationships between Mr. Dauer and any director or executive officer of the Company. Additionally, there are no transactions between Mr. Dauer and the Company and/or its subsidiaries that would be required to be reported under Item 404(a) of Regulation S-K.

  

Item 9.01 Financial Statement and Exhibits.

  (d) Exhibits.
     
  104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

1

 

       

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  CYREN LTD.
     
Dated: January 17, 2023    
  By: /s/ Brian Dunn
  Name: Brian Dunn
  Title: General Counsel

 

 

2

 

1 Year CYREN Chart

1 Year CYREN Chart

1 Month CYREN Chart

1 Month CYREN Chart